Spartan Bioscience and SUEZ Develop On-Site Legionella Molecular Test
OTTAWA, Ontario — Spartan Bioscience, a DNA diagnostics company, and SUEZ’s Water Technologies and Solutions (“SUEZ”), the company’s global business unit with global capabilities to help solve global water, wastewater, and process challenges, have partnered to bring to market the world’s first on-site molecular (qPCR) Legionella test to their customers. Spartan’s test quickly determines the amount of Legionella bacteria in a water source.
Legionella is a common bacterium that can infect the water systems of large buildings. When infected water systems release aerosolized water droplets contaminated with Legionella, building occupants can breathe in the contaminated air and contract Legionnaires’ disease, a pneumonia that is fatal in one in 10 people.